Impact of severe SARS-CoV-2 infection on nutritional status and subjective functional loss in a prospective cohort of COVID-19 survivors.
COVID-19
nutrition & dietetics
rehabilitation medicine
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
14 07 2021
14 07 2021
Historique:
entrez:
15
7
2021
pubmed:
16
7
2021
medline:
20
7
2021
Statut:
epublish
Résumé
The nutritional sequelae of COVID-19 have not been explored in a large cohort study. To identify factors associated with the change in nutritional status between discharge and 30 days post-discharge (D30). Secondary objectives were to determine the prevalence of subjective functional loss and severe disability at D30 and their associated factors. Collected data included symptoms, nutritional status, self-evaluation of food intake, Performance Status (PS) Scale, Asthenia Scale, self-evaluation of strength (SES) for arms and legs at discharge and at D30. An SES <7 was used to determine subjective functional loss. A composite criteria for severe disability was elaborated combining malnutrition, subjective functional loss and PS >2. Patients were classified into three groups according to change in nutritional status between discharge and D30 (persistent malnutrition, correction of malnutrition and the absence of malnutrition). Of 549 consecutive patients hospitalised for COVID-19 between 1 March and 29 April 2020, 130 died including 17 after discharge (23.7%). At D30, 312 patients were at home, 288 (92.3%) of whom were interviewed. Of the latter, 33.3% were malnourished at discharge and still malnourished at D30, while 23.2% were malnourished at discharge but no longer malnourished at D30. The highest predictive factors of persistent malnutrition were intensive care unit (ICU) stay (OR=3.42, 95% CI: 2.04 to 5.75), subjective functional loss at discharge (OR=3.26, 95% CI: 1.75 to 6.08) and male sex (OR=2.39, 95% CI: 1.44 to 3.97). Subjective functional loss at discharge (76.8%) was the main predictive factor of subjective functional loss at D30 (26.3%) (OR=32.6, 95% CI: 4.36 to 244.0). Lastly, 8.3% had a severe disability, with a higher risk in patients requiring an ICU stay (OR=3.39, 95% CI: 1.43 to 8.06). Patients who survived a severe form of COVID-19 had a high risk of persistent malnutrition, functional loss and severe disability at D30. We believe that nutritional support and rehabilitation should be strengthened, particularly for male patients who were admitted in ICU and had subjective functional loss at discharge. NCT04451694.
Identifiants
pubmed: 34261689
pii: bmjopen-2021-048948
doi: 10.1136/bmjopen-2021-048948
pmc: PMC8282420
doi:
Banques de données
ClinicalTrials.gov
['NCT04451694']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e048948Informations de copyright
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
JPEN J Parenter Enteral Nutr. 2019 Jan;43(1):32-40
pubmed: 30175461
Biol Sex Differ. 2020 Sep 18;11(1):53
pubmed: 32948238
JAMA. 2020 Aug 25;324(8):739-740
pubmed: 32777028
Neurol Sci. 2020 Aug;41(8):2029-2031
pubmed: 32617738
Age Ageing. 2019 Jan 1;48(1):16-31
pubmed: 30312372
Otolaryngol Head Neck Surg. 2020 Jul;163(1):3-11
pubmed: 32369429
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95
pubmed: 12900694
N Engl J Med. 2011 Apr 7;364(14):1293-304
pubmed: 21470008
Clin Nutr. 2009 Apr;28(2):134-40
pubmed: 19223093
Adv Nutr. 2021 Mar 05;:
pubmed: 33751020
Ann Intern Med. 2020 Jun 2;172(11):726-734
pubmed: 32282894
Am J Respir Crit Care Med. 2016 Oct 1;194(7):831-844
pubmed: 26974173
Int Forum Allergy Rhinol. 2020 Jul;10(7):821-831
pubmed: 32329222
N Engl J Med. 1948 Aug 19;239(8):299-305
pubmed: 18875995
Am J Clin Oncol. 1982 Dec;5(6):649-55
pubmed: 7165009
Age Ageing. 2014 Nov;43(6):748-59
pubmed: 25241753
Eur J Clin Nutr. 2020 Jun;74(6):871-875
pubmed: 32322046
Clin Nutr. 2019 Feb;38(1):1-9
pubmed: 30181091
PLoS One. 2018 Nov 15;13(11):e0206831
pubmed: 30439974
Clin Nutr. 2021 Jan;40(1):174-180
pubmed: 32430249
Clin Nutr. 2020 Jul;39(7):1983-1987
pubmed: 32425292
J Clin Neurosci. 2020 Aug;78:1-7
pubmed: 32563494
Calcif Tissue Int. 2019 Jul;105(1):1-14
pubmed: 30972475
Arthritis Rheum. 2007 Apr 15;57(3):429-39
pubmed: 17394228
J Am Med Dir Assoc. 2014 Sep;15(9):630-4
pubmed: 24947762
J Neural Transm (Vienna). 2018 Jun;125(6):925-930
pubmed: 29470631
Aging Dis. 2020 May 9;11(3):668-678
pubmed: 32489711
Sports Med. 2017 Nov;47(11):2341-2361
pubmed: 28573401
J Gerontol A Biol Sci Med Sci. 2008 Aug;63(8):829-34
pubmed: 18772470
Rev Neurol. 2020 May 1;70(9):311-322
pubmed: 32329044
Arch Public Health. 2014 Dec 18;72(1):45
pubmed: 25810912
Nat Med. 2021 Apr;27(4):601-615
pubmed: 33753937
Am J Respir Crit Care Med. 2006 Sep 1;174(5):538-44
pubmed: 16763220